Canopy Growth (CGC) Other Accumulated Expenses (2019 - 2026)
Canopy Growth (CGC) posted Other Accumulated Expenses of $6.5 million for Q1 2026, down 73.78% sequentially from $24.8 million in Q4 2025, and down 63.33% YoY from $17.7 million in Q1 2025.
Canopy Growth (CGC) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
Canopy Growth has reported Other Accumulated Expenses for 8 years, with the latest figure at $6.5 million in Q1 2026.
- Quarterly Other Accumulated Expenses fell 63.33% year-over-year to $6.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.5 million (down 63.33% YoY) and the FY2026 annual result came in at $6.5 million, down 63.33% from the prior year.
- Other Accumulated Expenses declined to $6.5 million in Q1 2026 per CGC's latest filing, from $24.8 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $69.3 million in Q1 2023 and troughed at $6.5 million in Q1 2026.
- A 5-year average of $34.9 million and a median of $35.7 million in 2024 frame the typical range for Other Accumulated Expenses.
- The widest YoY moves for Other Accumulated Expenses: up 190.76% in 2025, down 88.7% in 2025.
- Over 5 years, Other Accumulated Expenses stood at $62.3 million in 2022, then plunged by 35.85% to $40.0 million in 2023, then sank by 78.66% to $8.5 million in 2024, then soared by 190.76% to $24.8 million in 2025, then sank by 73.78% to $6.5 million in 2026.
- According to Business Quant data, Other Accumulated Expenses over the past three periods registered $6.5 million, $24.8 million, and $7.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Canopy Growth | 434.93 Mn | 187.92 Mn | 16.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 25.55 Mn |
| Mar 31, 2026 | 6.50 Mn |
| Dec 31, 2025 | 24.79 Mn |
| Sep 30, 2025 | 6.95 Mn |
| Jun 30, 2025 | 7.22 Mn |
| Mar 31, 2025 | 17.73 Mn |
| Dec 31, 2024 | 8.53 Mn |
| Sep 30, 2024 | 11.95 Mn |
| Jun 30, 2024 | 63.87 Mn |
| Mar 31, 2024 | 35.67 Mn |
| Dec 31, 2023 | 39.96 Mn |
| Sep 30, 2023 | 10.12 Mn |
| Jun 30, 2023 | 48.59 Mn |
| Mar 31, 2023 | 69.35 Mn |
| Dec 31, 2022 | 62.29 Mn |
| Sep 30, 2022 | 61.25 Mn |
| Jun 30, 2022 | 68.20 Mn |
| Mar 31, 2022 | 50.80 Mn |
| Dec 31, 2021 | 63.23 Mn |
| Sep 30, 2021 | 29.96 Mn |